One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.

Autor: Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A, Evans DB, Yao, James C, Hassan, Manal, Phan, Alexandria, Dagohoy, Cecile, Leary, Colleen, Mares, Jeannette E, Abdalla, Eddie K, Fleming, Jason B, Vauthey, Jean-Nicolas

Publikováno v: Journal of Clinical Oncology; 6/20/2008, Vol. 26 Issue 18, p3063-3072, 10p

Three biomarkers (HER2, PD-L1, and microsatellite status) in a large cohort of metastatic gastroesophageal adenocarcinomas: The MD Anderson Cancer Center experience.

Autor: Sewastjanow-Silva M; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Kwiatkowski E; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Yamashita K; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Abdelhakeem A; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Yoshimura K; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Vicentini ER; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Pizzi MP; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Jin J; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Fan Y; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Zou G; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Wang L; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Yin F; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Dhar SS; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Blum Murphy M; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Mares JE; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Li JJ; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Gan Q; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Waters RE; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Rogers JE; Department of Pharmacy Clinical Programs, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ajani JA; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Publikováno v: International journal of cancer [Int J Cancer] 2024 Dec 15; Vol. 155 (12), pp. 2277-2286. Date of Electronic Publication: 2024 Jul 12.

Utility of endoscopic ultrasound-guided fine-needle aspiration of regional lymph nodes that are proximal to and far from the primary distal esophageal carcinoma.

Autor: Shimodaira Y; Department of Gastrointestinal Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Slack RS; Department of Biostatistics, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Harada K; Department of Gastrointestinal Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Bhutani MS; Department of Gastroenterology, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Elimova E; Department of Gastrointestinal Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Staerkel GA; Department of Anatomic Pathology, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Sneige N; Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Erasmus J; Department of Diagnostic Radiology, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Shiozaki H; Department of Gastrointestinal Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Charalampakis N; Department of Gastrointestinal Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Planjery V; Department of Gastrointestinal Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Kaya DM; Department of Gastrointestinal Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Amlashi FG; Department of Gastrointestinal Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Blum MA; Department of Gastrointestinal Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Skinner HD; Department of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Minsky BD; Department of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Maru DM; Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Hofstetter WL; Department of Thoracic and Cardiovascular Surgery, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Swisher SG; Department of Thoracic and Cardiovascular Surgery, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Mares JE; Department of Gastrointestinal Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Rogers JE; Department of Pharmacy, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Lin QD; Department of Gastrointestinal Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Ross WA; Department of Gastroenterology, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Weston B; Department of Gastroenterology, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Lee JH; Department of Gastroenterology, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Ajani JA; Department of Gastrointestinal Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.

Publikováno v: Oncotarget [Oncotarget] 2017 May 23; Vol. 8 (45), pp. 79356-79365. Date of Electronic Publication: 2017 May 23 (Print Publication: 2017).

Metastatic Gastroesophageal Adenocarcinoma Patients Treated with Systemic Therapy Followed by Consolidative Local Therapy: A Nomogram Associated with Long-Term Survivors.

Autor: Shiozaki H; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Tex., USA., Slack RS, Chen HC, Elimova E, Planjery V, Charalampakis N, Wadhwa R, Shimodaira Y, Skinner H, Lee JH, Weston B, Bhutani MS, Blum-Murphy M, Rogers JE, Maru DM, Matamoros A Jr, Sagebiel T, Estrella JS, Das P, Hofstetter WL, Mares JE, Mizrak Kaya D, Harada K, Lin Q, Minsky BD, Badgwell BD, Ajani JA

Publikováno v: Oncology [Oncology] 2016; Vol. 91 (1), pp. 55-60. Date of Electronic Publication: 2016 Apr 28.